US Broker Ratings

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Uncovering a 105% Upside Potential in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is a notable player in the biotechnology industry, attracting investor attention with its ambitious pipeline and impressive potential upside. As a..

Fulgent Genetics, Inc. (FLGT) Stock Report: Analyzing a 20.71% Potential Upside in the Diagnostics Sector

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector, specifically within diagnostics and research, is attracting attention from investors due to its promising..

CareDx, Inc. (CDNA) Stock Analysis: Navigating a 33.57% Potential Upside in Transplant Diagnostics

For investors seeking exposure to the burgeoning healthcare sector, CareDx, Inc. (NASDAQ: CDNA) presents an intriguing opportunity within the diagnostics and research industry. With its headquarters..

Arcus Biosciences, Inc. (RCUS) Investor Outlook: Exploring a 48.95% Upside Potential

Arcus Biosciences, Inc. (NASDAQ: RCUS), a key player in the biotechnology sector, has captured the attention of investors with its ambitious cancer therapy pipeline and significant..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring Its Potential 35.79% Upside

Nutex Health Inc. (NUTX), a Houston-based healthcare services and operations company, has recently caught the attention of investors with its impressive revenue growth and promising analyst..

Embecta Corp. (EMBC): Investor Outlook Reveals 30.62% Potential Upside Amidst Mixed Ratings

Embecta Corp. (NASDAQ: EMBC), a pivotal player in the healthcare sector’s medical instruments and supplies industry, has been making waves with its specialized focus on diabetes..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 67% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm rooted in the development of targeted cancer therapies, has captured the attention of investors with its promising pipeline..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Biotechnology Innovator with 112% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering player in the biotechnology sector, has captured the attention of investors with its groundbreaking work in genome editing. With..

iRadimed Corporation (IRMD) Stock Analysis: Strong Revenue Growth in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD) has positioned itself as a noteworthy player in the medical devices sector, particularly in the niche of MRI-compatible equipment. With a market..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling an 83.84% Potential Upside in the Biotech Arena

Bicara Therapeutics Inc. (BCAX) is making waves in the biotechnology sector with a compelling narrative that carries significant potential for investors eyeing the healthcare industry. Based..

SI-BONE, Inc. (SIBN) Investor Outlook: 23.99% Potential Upside and Strong Buy Ratings Fuel Growth Expectations

SI-BONE, Inc. (NASDAQ: SIBN) is capturing investor attention in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $906.01 million, the..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Opportunities with an 18% Potential Upside

As STAAR Surgical Company (NASDAQ: STAA) continues to make strides in the healthcare sector, investors are keenly observing the developments within this medical instruments and supplies..

Gyre Therapeutics, Inc. (GYRE) Stock Report: A Biotech Gem with a Potential 137% Upside

For investors seeking opportunities in the biotechnology sector, Gyre Therapeutics, Inc. (NASDAQ: GYRE) presents an intriguing prospect, particularly with a potential upside of 137.78%. Specializing in..

Dynatrace, Inc. (DT) Stock Analysis: Exploring a 37% Potential Upside for Investors

Dynatrace, Inc. (NYSE: DT), a formidable player in the technology sector, specifically within the software application industry, presents a compelling investment opportunity with a promising potential..

Similarweb Ltd. (SMWB) Stock Analysis: Eyeing a 68.6% Upside with Strong Buy Ratings

As investors scour the technology sector for promising opportunities, Similarweb Ltd. (NASDAQ: SMWB) emerges as a compelling contender. This Israel-based software application company, renowned for its..

Procore Technologies, Inc. (PCOR) Stock Analysis: Unpacking a 16.52% Potential Upside

Procore Technologies, Inc. (NYSE: PCOR) has steadily carved out a niche in the technology sector, specifically within the application software industry. With a robust market capitalization..

Salesforce, Inc. (CRM) Stock Analysis: Riding the Wave with a 24% Potential Upside

Salesforce, Inc. (CRM), a powerhouse in the technology sector, continues to capture investor attention with its robust customer relationship management (CRM) solutions and strategic expansions. As..

SAP SE (SAP) Stock Analysis: Unpacking a 39.60% Potential Upside for Investors

SAP SE (NYSE: SAP), a behemoth in the technology sector, continues to draw considerable attention from investors worldwide. With a market capitalization of $284.03 billion, SAP’s..

Datadog, Inc. (DDOG) Stock Analysis: 47.40% Potential Upside Captivates Investors

Datadog, Inc. (NASDAQ: DDOG), a prominent player in the technology sector, has been making waves with its robust cloud-based monitoring and security solutions. Headquartered in New..

Paychex, Inc. (PAYX) Investor Outlook: Navigating a 9.42% Potential Upside in a Competitive Sector

Paychex, Inc. (NASDAQ: PAYX), a stalwart in the technology sector, operates within the dynamic software – application industry. With a substantial market capitalization of $40.07 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds